176 related articles for article (PubMed ID: 31821545)
1. Integrated cancer networks improve compliance with national guidelines and outcomes for resectable gastric cancer.
Thiels CA; Hanson KT; Habermann EB; Boughey JC; Grotz TE
Cancer; 2020 Mar; 126(6):1283-1294. PubMed ID: 31821545
[TBL] [Abstract][Full Text] [Related]
2. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE
Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687
[TBL] [Abstract][Full Text] [Related]
3. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery.
Morgan JW; Ji L; Friedman G; Senthil M; Dyke C; Lum SS
JAMA Surg; 2015 Jan; 150(1):37-43. PubMed ID: 25426671
[TBL] [Abstract][Full Text] [Related]
4. Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes.
Visser BC; Ma Y; Zak Y; Poultsides GA; Norton JA; Rhoads KF
HPB (Oxford); 2012 Aug; 14(8):539-47. PubMed ID: 22762402
[TBL] [Abstract][Full Text] [Related]
5. Compliance with gastric cancer guidelines is associated with improved outcomes.
Worhunsky DJ; Ma Y; Zak Y; Poultsides GA; Norton JA; Rhoads KF; Visser BC
J Natl Compr Canc Netw; 2015 Mar; 13(3):319-25. PubMed ID: 25736009
[TBL] [Abstract][Full Text] [Related]
6. National Trends in Multimodality Therapy for Locally Advanced Gastric Cancer.
Sada YH; Smaglo BG; Tran Cao HS; Mok H; Musher BL; Massarweh NN
J Surg Res; 2019 May; 237():41-49. PubMed ID: 30694790
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
Cats A; Jansen EPM; van Grieken NCT; Sikorska K; Lind P; Nordsmark M; Meershoek-Klein Kranenbarg E; Boot H; Trip AK; Swellengrebel HAM; van Laarhoven HWM; Putter H; van Sandick JW; van Berge Henegouwen MI; Hartgrink HH; van Tinteren H; van de Velde CJH; Verheij M;
Lancet Oncol; 2018 May; 19(5):616-628. PubMed ID: 29650363
[TBL] [Abstract][Full Text] [Related]
8. Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United States.
Datta J; McMillan MT; Ruffolo L; Lowenfeld L; Mamtani R; Plastaras JP; Dempsey DT; Karakousis GC; Drebin JA; Fraker DL; Roses RE
Ann Surg Oncol; 2016 Sep; 23(9):2936-45. PubMed ID: 27090793
[TBL] [Abstract][Full Text] [Related]
9. Improved guideline compliance and textbook oncologic outcomes among patients undergoing multimodal treatment and minimally invasive surgery for locally advanced gastric cancer.
Rawicz-Pruszyński K; Tsilimigras DI; Endo Y; Munir MM; Katayama E; Benavides JG; Sędłąk K; Pelc Z; Pawlik TM
J Gastrointest Surg; 2024 Jan; 28(1):10-17. PubMed ID: 38353069
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis.
Stumpf PK; Amini A; Jones BL; Koshy M; Sher DJ; Lieu CH; Schefter TE; Goodman KA; Rusthoven CG
Cancer; 2017 Sep; 123(17):3402-3409. PubMed ID: 28513823
[TBL] [Abstract][Full Text] [Related]
11. Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes.
Volpe CM; Driscoll DL; Douglass HO
Ann Surg Oncol; 2000 Mar; 7(2):139-44. PubMed ID: 10761793
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
In H; Kantor O; Sharpe SM; Baker MS; Talamonti MS; Posner MC
Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Gastric Resection in the Establishment of a Comprehensive Oncologic Robotic Program.
Balbona J; Chen L; Malafa MP; Hodul PJ; Dineen SP; Mehta R; Mhaskar RS; Pimiento JM
J Surg Res; 2020 Aug; 252():30-36. PubMed ID: 32222591
[TBL] [Abstract][Full Text] [Related]
14. Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline-directed treatment for stage II and III disease.
Kolarich A; George TJ; Hughes SJ; Delitto D; Allegra CJ; Hall WA; Chang GJ; Tan SA; Shaw CM; Iqbal A
Cancer; 2018 Sep; 124(17):3510-3519. PubMed ID: 29984547
[TBL] [Abstract][Full Text] [Related]
15. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
[TBL] [Abstract][Full Text] [Related]
17. Use of endoscopic ultrasound in the preoperative staging of gastric cancer: a multi-institutional study of the US gastric cancer collaborative.
Spolverato G; Ejaz A; Kim Y; Squires MH; Poultsides GA; Fields RC; Schmidt C; Weber SM; Votanopoulos K; Maithel SK; Pawlik TM
J Am Coll Surg; 2015 Jan; 220(1):48-56. PubMed ID: 25283742
[TBL] [Abstract][Full Text] [Related]
18. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
[TBL] [Abstract][Full Text] [Related]
19. Implications of inadequate lymph node staging in resectable gastric cancer: a contemporary analysis using the National Cancer Data Base.
Datta J; Lewis RS; Mamtani R; Stripp D; Kelz RR; Drebin JA; Fraker DL; Karakousis GC; Roses RE
Cancer; 2014 Sep; 120(18):2855-65. PubMed ID: 24854027
[TBL] [Abstract][Full Text] [Related]
20. Adoption of evidence-based novel therapies in the treatment of gastric cancer: A national observational study.
Mokdad AA; Ali A; Yopp AC; Polanco PM; Nassour I; Mansour JC; Choti MA; Minter RM; Wang SC; Porembka MR
Cancer; 2018 Mar; 124(6):1122-1131. PubMed ID: 29211302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
